Arch Biopartners Inc.
Arch Biopartners Inc. (ARCH.V) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARCH.V · as of Jun 8, 2026
Key Statistics
Explore Arch Biopartners Inc. Data
arch.v stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
arch.v competitorsARCH.V
BLO.CN
COV.V
CXXI.CN
DTC.CN
IAN.CNStock Performance
Full HistoryAbout Arch Biopartners Inc.
Arch Biopartners Inc. a biotechnology company, develops technologies for medical or commercial impact. It focuses on developing its lead drug candidate Metablok to treat or prevent dipeptidase-1 medi…
what is arch biopartners inc. · arch.v stock overview · arch biopartners inc. company profile · who is arch biopartners inc. ceo · arch.v TSXV · arch biopartners inc. headquarters · arch biopartners inc. business segments
About Stock Overview & Key Data
Arch Biopartners Inc. (ARCH.V) is a Healthcare company in the Biotechnology industry, listed on TSXV since May 7, 2010. As of the latest trading session, ARCH.V stock price is $0.49, with a market capitalization of $33.3M. The stock has returned -73.80% over the past 12 months and -59.84% year-to-date.
In fiscal year 2025, Arch Biopartners Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arch Biopartners Inc. (ARCH.V) stock price is $0.49. The stock is traded on TSXV under the ticker symbol ARCH.V. The 52-week range is $0.39 – $1.95.